Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 526 - 550 of 646 in total

(S)-wiskostatin

Experimental

6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone

Experimental

5-Bromothienyldeoxyuridine

Experimental

4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol

Experimental

6-bromoindirubin-3'-oxime

Experimental

1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole

Experimental

N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]-4-methoxybenzohydrazide

Experimental

8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE

Experimental

Sulfabromomethazine

Vet approved

Sorivudine

Sorivudine has been used in trials studying the treatment of Chickenpox and HIV Infections.
Investigational

Haloxazolam

Experimental
Illicit

5-Bromo-2'-deoxyuridine 5'-(dihydrogen phosphate)

Experimental

R048-8071

Experimental

Bromo-Willardiine

Experimental

Bromo-WR99210

Experimental

5-Bromoindirubin

Experimental

Crolibulin

Crolibulin has been used in trials studying the treatment of Solid Tumor and Anaplastic Thyroid Cancer.
Investigational

4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN

Experimental

(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL

Experimental

N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide

Experimental

(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE

Experimental

3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile

Experimental

Brotizolam

Brotizolam is a sedative-hypnotic thienodiazepine drug which is a benzodiazepine analog. It demonstrates anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant effects. Brotizolam has similar effects to short-acting benzodiazepines such as triazolam. Brotizolam is indicated for 2-4 weeks of treatment for severe or debilitating insomnia. Brotizolam is an extremely potent...
Investigational
Withdrawn

Ertiprotafib

Ertiprotafib belongs to a novel class of insulin sensitizers developed for treatment of type 2 diabetes. In insulin-resistant rodent models, ertiprotafib and a close analog lowered both fasting blood glucose and insulin levels and improved glycemic excursion during an oral glucose tolerance test.
Investigational

3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE

Experimental
Displaying drugs 526 - 550 of 646 in total